News from arix bioscience plc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

03 Oct, 2019, 07:00 BST Arix Bioscience plc: 2019 Capital Markets Day

Arix Bioscience plc ("Arix") (LSE: ARIX) a global venture capital company focused on investing in and building breakthrough biotech companies, is...


30 Sep, 2019, 08:09 BST Arix Bioscience plc: Arix Co-leads EUR 20 Million Series A Investment Round in STipe Therapeutics

Arix Bioscience plc ("Arix") (LSE: ARIX), a global venture capital company focused on investing in and building breakthrough biotech companies, today ...


17 Sep, 2019, 08:30 BST Arix Bioscience plc: Amplyx Unveils Expanded Pipeline and Reports Phase 2 Data from Lead Programme

Arix Bioscience plc (LSE: ARIX) ("Arix"), a global venture capital company focused on investing in and building breakthrough biotech companies, today ...


13 Sep, 2019, 12:30 BST Arix Bioscience plc - Imara Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering in the United States

Arix Bioscience plc (LSE: ARIX) ("Arix"), a global venture capital company focused on investing in and building breakthrough biotech companies, today ...


28 Aug, 2019, 09:53 BST Arix Bioscience plc: Interim Results for the Six Months Ended 30 June 2019

This Announcement Contains Inside Information Within The Meaning Of The EU Market Abuse Regulation No.596/2014 Arix Bioscience plc (LSE: ARIX)...


18 Jun, 2019, 13:37 BST Arix Bioscience plc: Imara Presents initial Phase 2a data for IMR-687

Arix Bioscience plc (LSE: ARIX) ("Arix"), a global venture capital company focused on investing and building breakthrough biotech companies, notes...


02 Apr, 2019, 07:59 BST Arix Bioscience plc: Aura Completes $40 Million Series D Financing

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF THE EU MARKET ABUSE REGULATION NO.596/2014 Arix's total interest in Aura...


01 Apr, 2019, 19:29 BST Arix Bioscience plc - Autolus Presents Initial AUTO1 Data at AACR

Arix Bioscience plc (LSE: ARIX) ("Arix"), a global venture capital company focused on investing in and building breakthrough biotech companies, notes ...


29 Mar, 2019, 20:05 GMT Arix Bioscience plc - Autolus Announces Conference Call to Discuss AUTO1 ALLCAR19 Data Presentation at the AACR Annual Meeting 2019

Arix Bioscience plc (LSE: ARIX) ("Arix"), a global venture capital company focused on investing in and building breakthrough biotech companies, today ...


18 Mar, 2019, 07:42 GMT Arix Bioscience plc: Arix Co-leads $63 Million Series B Investment Round for Imara

This Announcement Contains Inside Information Within the Meaning of The EU Market Abuse Regulation No.596/2014 Arix co-leads a $63 million Series B...


19 Feb, 2019, 14:08 GMT Arix Bioscience plc: Autolus Announces Updated Results From CARPALL Trial

Arix Bioscience plc (LSE: ARIX) ("Arix"), a global healthcare and life science company supporting medical innovation, notes that its portfolio...


19 Feb, 2019, 07:00 GMT Arix Bioscience plc: Management and Board Changes

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF THE EU MARKET ABUSE REGULATION NO.596/2014 Joe Anderson appointed as CEO Arix...


14 Feb, 2019, 07:25 GMT Arix Bioscience plc: Harpoon Closes Initial Public Offering

This Announcement Contains Inside Information Within The Meaning Of The EU Market Abuse Regulation No.596/2014 Harpoon IPO has closed Arix retains a...


28 Dec, 2018, 07:00 GMT Arix Bioscience plc: Harpoon Announces Proposed Public Offering in the United States

Arix Bioscience plc (LSE: ARIX) ("Arix"), a global healthcare and life science company supporting medical innovation, today notes that its portfolio...


11 Dec, 2018, 07:00 GMT Arix Bioscience plc: Arix Appoints Dr Christian Schetter as Entrepreneur in Residence (EIR)

Experienced industry Executive joins investment team to support portfolio development Arix Bioscience plc (LSE:ARIX) ("Arix"), a global healthcare...


03 Dec, 2018, 08:27 GMT Arix Bioscience plc: Autolus Announces Update on AUTO4 and AUTO5 Programmes

Arix Bioscience plc (LSE: ARIX) ("Arix"), a global healthcare and life science company supporting medical innovation notes its portfolio company,...


03 Dec, 2018, 08:25 GMT Arix Bioscience plc: Autolus Presents Initial AUTO3 Clinical Data at ASH

Arix Bioscience plc (LSE: ARIX) ("Arix"), a global healthcare and life science company supporting medical innovation notes that its portfolio...


15 Nov, 2018, 07:00 GMT Arix Bioscience plc: Pharmaxis Releases Positive Results of Phase 1 Clinical Trial for Second LOXL2 Inhibitor Compound

Arix Bioscience plc ("Arix") (LSE: ARIX), a global healthcare and life science company supporting medical innovation, is pleased to note that...


12 Nov, 2018, 07:18 GMT Arix Bioscience plc: Arix Participates in Harpoon $70m Series C Investment Round

This Announcement Contains Inside Information Within the Meaning of the EU Market Abuse Regulation No.596/2014 Arix's total interest in Harpoon...


02 Nov, 2018, 11:42 GMT Autolus Therapeutics to Present New Data at the ASH Annual Meeting

Arix Bioscience plc (LSE:ARIX) ("Arix"), a global healthcare and life science company supporting medical innovation notes one of its Group...


30 Oct, 2018, 15:54 GMT Arix Bioscience plc - Aura Biosciences Reports Positive Phase 1b/2 Clinical Data for AU-011

Multiple doses of AU-011 are well tolerated, with vision preservation observed at 12 to 18 months All Patients met preliminary efficacy endpoint to...


25 Oct, 2018, 17:57 BST Arix Bioscience plc - Arix to Host Oncology KOL Event on October 30, 2018

Webcast to begin at 12:00pm ET Focus on recent developments in synthetic lethality and bi-specific antibodies within oncology Arix Bioscience plc...


24 Oct, 2018, 07:00 BST Arix Bioscience plc - LogicBio Announces Closing of Initial Public Offering

This Announcement Contains Inside Information Within the Meaning of the EU Market Abuse Regulation No.596/2014 LogicBio IPO has closed Arix retains a ...


19 Oct, 2018, 07:12 BST Arix Bioscience plc: LogicBio Prices Nasdaq IPO

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF THE EU MARKET ABUSE REGULATION NO.596/2014 Third public listing of an Arix...


11 Oct, 2018, 09:20 BST Arix Bioscience plc : Pharmaxis Releases Positive Results of Phase 1 Clinical Trial for LOXL2 Inhibitor Compound

Arix Bioscience plc ("Arix") (LSE: ARIX), a global healthcare and life science company supporting medical innovation, is pleased to note that its...